Retrovirology · 2011 · 23 citations · 59 references
Life SciencesImmunologyInfectious DiseasesImmunizationMolecular VirologyVaccinologyAntiviral ImmunityImmune Response To VaccinationInterferon ResponsesVaccinationViral InfectionsViral VaccinesAdenoviral Vaccine VectorsAdenoviral VectorsAdenovirus VaccinesAdenovirus VectorsAntiviral T Cell ResponsesCellular Immune Response To VirusesProphylactic VaccinationVaccine-induced Antiviral Immunity
BACKGROUND: Type I interferons (IFNs) exhibit direct antiviral effects, but also distinct immunomodulatory properties. In this study, we analyzed type I IFN subtypes for their effect on prophylactic adenovirus-based anti-retroviral vaccination of mice against Friend retrovirus (FV) or HIV. RESULTS: Mice were vaccinated with adenoviral vectors encoding FV Env and Gag proteins alone or in combination with vectors encoding IFNα1, IFNα2, IFNα4, IFNα5, IFNα6, IFNα9 or IFNβ. Only the co-administration of adenoviral vectors encoding IFNα2, IFNα4, IFNα6 and IFNα9 resulted in strongly improved immune protection of vaccinated mice from subsequent FV challenge infection with high control over FV-induced splenomegaly and reduced viral loads. The level of protection correlated with augmented virus-specific CD4(+) T cell responses and enhanced antibody titers. Similar results were obtained when mice were vaccinated against HIV with adenoviral vectors encoding HIV Env and Gag-Pol in combination with various type I IFN encoding vectors. Here mainly CD4(+) T cell responses were enhanced by IFNα subtypes. CONCLUSIONS: Our results indicate that certain IFNα subtypes have the potential to improve the protective effect of adenovirus-based vaccines against retroviruses. This correlated with augmented virus-specific CD4(+) T cell and antibody responses. Thus, co-expression of select type I IFNs may be a valuable tool for the development of anti-retroviral vaccines.
59
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Marc G. Ghany, Doris B. Strader, David L. Thomas et al. · Hepatology · 2008 · 3K citations · Full text
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
Stephen Cobbold, A. Jayasuriya, Anthony A. Nash et al. · Nature · 1984 · 874 citations
Punnee Pitisuttithum, Peter B. Gilbert, Marc Gurwith et al. · The Journal of Infectious Diseases · 2006 · 828 citations · Full text